Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.

Findings indicate that baloxavir may reduce hospital admission risks for high-risk patients and shorten symptom duration without increasing adverse events. One factor in distinguishing baloxavir ...

A network meta-analysis of 73 trials comparing the effectiveness of flu antivirals suggests that only baloxavir (Xofluza) may ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Opens in a new tab or window Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to ...